Canadian Cancer Society top charitable funder in pediatric cancer research:
More investments needed for late effects of cancer treatment in children
While CEO of the CCS B.C. and Yukon (CCSBCY) welcomes the report and the CCSBCY's contribution, she stresses the need for further funding to address the impact cancer treatments have on childhood survivors later in life.
"While I am proud of the CCSBCY's contribution, further investments in research to deliver safer long-lasting treatments needs to be made," says
According to Canadian Cancer Society Statistics, 82 per cent of children under the age of 14 will survive at least five years after diagnosis but two thirds of children have at least one chronic or late-occurring effect from cancer therapy. At least one third have a major, serious, life-threatening complication.
Pioneering research on childhood cancer treatment late effects is being led by a team of B.C. based cancer researchers.
In 2008 the Canadian Cancer Society awarded Senior Scientist Mary McBride more than
"We have come a long way in improving cancer outcomes in children but our ultimate success will be in preventing cancer before it even starts in young people," says Kaminsky. "That is our vision and with continued public and donor support we believe this is within our reach."
The Canadian Cancer Society is a national community-based organization of volunteers whose mission is the eradication of cancer and the enhancement of the quality of life of people living with cancer. When you want to know more about cancer, visit our website www.cancer.ca or call our toll-free, bilingual Cancer Information Service at 1 888 939-3333.
For further information: or to speak to Barbara Kaminsky please contact: Catherine Loiacono, Manager, Media Relations, Canadian Cancer Society, B.C. and Yukon Division, Phone: (604) 675-7340, cell: (604) 837-5643
Share this article